Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein (GCKR) Inhibition: GCKR-Leu446Pro Variant in Look AHEAD

BACKGROUND: Glucokinase regulatory protein (GCKR) inhibitors offer a novel treatment approach for glucose control in diabetes; however their cardiometabolic effects, particularly in relation to increased triglycerides and C-reactive protein (CRP) levels are of concern. GCKR Leu446Pro is a common var...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Circ Cardiovasc Genet
Главные авторы: Belalcazar, L. Maria, Papandonatos, George D., Erar, Bahar, Peter, Inga, Alkofide, Hadeel, Balasubramanyam, Ashok, Brautbar, Ariel, Kahn, Steven E., Knowler, William C., Ballantyne, Christie M., McCaffery, Jeanne M., Huggins, Gordon S.
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758870/
https://ncbi.nlm.nih.gov/pubmed/26578543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGENETICS.115.001192
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы